Serotonin2C receptor blockade and thermoregulation during exercise in the heat

Medicine and Science in Sports and Exercise

Volumn 37, Issue 3, 2005, Pages 389-394

  Strachan, Arthur T ^a,c   Leiper, John B ^a   Maughan, Ronald J ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

Author keywords

Cortisol; Prolactin; Receptors; Rectal temperature; Serotonin2c

Indexed keywords

PIZOTIFEN; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; HYDROCORTISONE; PROLACTIN; SEROTONIN ANTAGONIST;

ADULT; ARTICLE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENVIRONMENT; ENVIRONMENTAL TEMPERATURE; ERGOMETER; EXERCISE; FEMALE; HEAT; HEAT ACCLIMATIZATION; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SIDE EFFECT; THERMOREGULATION; BICYCLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ENDURANCE; PHYSIOLOGY; TASK PERFORMANCE;

ADULT; BICYCLING; BODY TEMPERATURE REGULATION; EXERCISE; FEMALE; HEAT; HUMANS; HYDROCORTISONE; MALE; PHYSICAL ENDURANCE; PIZOTYLINE; PROLACTIN; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN ANTAGONISTS; TASK PERFORMANCE AND ANALYSIS;

EID: 14844339661     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000155397.42481.53     Document Type: Article

References (30)

1. ASTRAND, P., and K. RODAHL. Temperature regulation. In: Textbook of Work Physiology: Physiological Bases of Exercise. New York: McGraw-Hill, 1986, pp. 583-590
2. BAILEY, S. P., J. M. DAVIS, and E. N. AHLBORN. Effect of increased brain serotonergic activity on endurance performance in the rat. Acta Physiol. Scand. 145:75-76, 1992.
3. BAILEY, S. P., J. M. DAVIS, and E. N. AHLBORN. Brain serotonergic activity affects endurance performance in the rat. Int. J. Sports Med. 6:330-333, 1993.
4. BAILEY, S. P., J. M. DAVIS, and E. N. AHLBORN. Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue. J. Appl. Physiol. 74:3006-3012, 1993.
5. BEN-JONATHAN, N. Dopamine: a prolactin-inhibiting hormone. Endocrine Rev. 6:564-589, 1985.
6. BLOMSTRAND, E., F. CELSING, and E. A. NEWSHOLME. Changes in plasma concentrations of aromatic and branch chain amino acids during sustained exercise in man and their possible role in fatigue. Acta Physiol. Scand. 133:115-121, 1988.
7. BOOTH, J., F. MARINO, and J. J. WARD. Improved running performance in hot humid conditions following whole body precooling. Med. Sci. Sports Exerc. 29:943-949, 1997.
8. BORG, G. Borg 's Perceived Exertion and Pain Scales. Champaign, IL: Human Kinetics, 1998, pp. 27-38
9. CLARK, W. G., and J. M. LIPTON. Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants. Neuro. Biobehav. Rev. 10:153-220, 1986.
10. DACIE, J. V., and S. M. LEWIS. Practical Haematology, 4th Ed. London: Churchill, 1968, pp. 45-49.
11. DE MEIRLEIR K., M. L'HERMITE-BALERIAUX, M. L. HERMITE, R. ROST, and W. HOLLMANN. Evidence for serotonergic control of exercise-induced prolactin secretion. Horm. Metab. Res. 17:380-381, 1985.
12. DILL, D. B., and D. L. COSTILL. Calculation of percentage changes in volumes of blood, plasma and red cells in dehydration. J. Appl. Physiol. 37:247-248, 1974.
13. FULLER, A., R. N. CARTER, and D. MITCHELL. Brain and abdominal temperatures at fatigue in rats exercising in the heat. J. Appl. Physiol. 84:877-883, 1998.
14. 1A receptor antagonist and a SSRI in vivo: effects on cell firing and extra cellular 5-HT. Br. J. Pharmacol. 115:1064-1070, 1995.
15. GONZALEZ-ALONSO, J., C. TELLER, S. L. ANDERSON, F. B. JENSEN, T. HYLDIG, and B. NIELSEN. Influence of body temperature on the development of fatigue during prolonged exercise in the heat. J. Appl. Physiol. 86:1032-1039, 1999.
16. HILLEGAART, V. Effect of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on core temperature. Psychopharmacology 103:291-290, 1991.
17. LIN, M. T., H. J. TSAY, W. H. SU, and F. Y. CHEUH. Changes in extracellular serotonin in the rat hypothalamus affect thermoregulatory function. Am. J. Physiol. 274:R1260-R1267, 1998.
18. 2C receptors. Psychopharmacology 123:333-339, 1996.
19. 2A/2C) antagonist. Int. J. Sports Med. 18:571-577, 1997.
20. NIELSEN, B., J. R. S. HALES, S. STRANGE, N. J. CHRISTENSEN, J. WALBERG, and B. SALTIN. Human circulatory and thermoregulatory adaptations with heat acclimation and exercise in a hot dry environment. J. Physiol. 460:467-485, 1993.
21. 2A receptor antagonists completely prevent the development of hyperthermia in an animal model of 5-HT syndrome. Brain Res. 890:23-31, 2001.
22. O'KEANE V., A. O'HANALON, M. WEBB, and T. G. DINAN. D-Fenfluramine prolactin response through the menstrual cycle: Evidence for an oestrogen-induced alteration. Clin. Endocrinol. 34: 289-292, 1991.
23. PANNIER, J. L., J. J. BOUCKAERT and R. A. LEFEBVRE. The antiserotonin agent pizotifen does not increase endurance performance in humans. Eur. J. Appl. Physiol. 72:175-178, 1995.
24. RAMANATHAN, L. N. A new weighing system for mean surface temperature of the human body. J. Appl. Physiol. 19:531, 1964.
25. SARGENT, P. A., R. HOCKNEY, B. DOWLING, G. CAMPLING, and P. J. COWEN. Adaptive changes in 5-HT neurotransmission during paroxetine treatment. J. Pyscopharmacol. 10:134, 1996.
26. SCHWARTZ, P. J., T. A. WEHR, N. E. ROSENTHAL, et al. Serotonin and thermoregulation: physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects. Neuropsychopharmacology 13:105-115, 1995.
27. 2 receptors in hyperthermia induced by p-chloramphetamine, a serotonin-releasing drug in mice. Eur. J. Pharmacol. 403:225-228, 2000.
28. VAN, DE KAR, L. D. 5-HT receptors involved in the regulation of hormone secretion: serotonergic neurons and receptors in the CNS. In: Handbook of Experimental Pharmacology, H. G. Baumgarten and M. Gothert (Eds.). Berlin: Springer, 1997, pp. 537-562.
29. WEBB, P. Heat storage and body temperature during cooling and re-warming. Eur. J. Appl. Physiol. 66:18-24, 1993.
30. WILSON, W. M., and R. J. MAUGHAN. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces capacity to perform prolonged exercise. Exp. Physiol. 77:921-924, 1992.